Certara Completes Acquisition of Chemaxon
October 02, 2024 16:15 ET
|
Certara
Certara completes acquiring Chemaxon, a leading cheminformatics company that develops scientific informatics software used by the life sciences industry.
Certara’s Simcyp Consortium Celebrates 25th Anniversary
September 24, 2024 08:00 ET
|
Certara
Certara, a global leader in model-informed drug development, today announced the celebration of the 25th anniversary of the Simcyp® Consortium.
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
September 18, 2024 08:00 ET
|
Certara
Certara shared the results from its collaboration with Ichnos Glenmark Innovation (IGI) on the first-in-human dose prediction and selection for ISB 2001.
Certara to Participate in Upcoming Investor Conferences
August 21, 2024 16:15 ET
|
Certara
RADNOR, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the...
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024 16:15 ET
|
Certara
Certara today announced the launch of Phoenix™ version 8.5 software, the pharmaceutical industry's gold standard in PK/PD modeling and simulation.
Certara Reports Second Quarter 2024 Financial Results
August 06, 2024 16:15 ET
|
Certara
RADNOR, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal...
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 09, 2024 16:45 ET
|
Certara
Certara has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software.
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 02, 2024 16:15 ET
|
Certara
RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second...
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
June 17, 2024 08:00 ET
|
Certara
Certara today unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers.
Certara to Participate in the Jefferies Global Healthcare Conference
May 29, 2024 16:15 ET
|
Certara
RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Jefferies Global...